Butalbital M (OH) en es it fr

Butalbital M (OH) Brand names, Butalbital M (OH) Analogs

Butalbital M (OH) Brand Names Mixture

  • Fiorinal C1/2 Cap (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)
  • Fiorinal C1/4 Cap (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)
  • Fiorinal Tab (Acetylsalicylic Acid + Butalbital + Caffeine)
  • Ratio-Tecnal (Acetylsalicylic Acid + Butalbital + Caffeine)
  • Ratio-Tecnal C 1/2 (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)
  • Ratio-Tecnal C1/4 (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)
  • Trianal Capsules (Acetylsalicylic Acid + Butalbital + Caffeine)
  • Trianal Tablet (Acetylsalicylic Acid + Butalbital + Caffeine)
  • Trianal-C 1/2 Capsule (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)

Butalbital M (OH) Chemical_Formula


Butalbital M (OH) RX_link


Butalbital M (OH) fda sheet

Butalbital M (OH) msds (material safety sheet)

Butalbital M (OH) Synthesis Reference

J. Am. Chem. Soc. 47, 2236 (1925)

Butalbital M (OH) Molecular Weight

224.256 g/mol

Butalbital M (OH) Melting Point

138-139 oC

Butalbital M (OH) H2O Solubility

1700 mg/L

Butalbital M (OH) State


Butalbital M (OH) LogP


Butalbital M (OH) Dosage Forms


Butalbital M (OH) Indication

Used in combination with acetaminophen or aspirin and caffeine for its sedative and relaxant effects in the treatment of tension headaches, migraines, and pain.

Butalbital M (OH) Pharmacology

Butalbital is a short to intermediate-acting barbiturate. Barbiturates act as nonselective depressants of the central nervous system (CNS), capable of producing all levels of CNS mood alteration from excitation to mild sedation, hypnosis, and deep coma. In sufficiently high therapeutic doses, barbiturates induce anesthesia.

Butalbital M (OH) Absorption

Well absorbed from the gastrointestinal tract and is expected to distribute to most tissues in the body.

Butalbital M (OH) side effects and Toxicity

Symptoms of acute barbiturate poisoning include drowsiness, confusion, coma, respiratory depression, hypotension, and shock.

Butalbital M (OH) Patient Information

This product may impair mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. Such tasks should be avoided while taking this product.
Alcohol and other CNS depressants may produce an additive CNS depression, when taken with this combination product, and should be avoided.
Butalbital may be habit-forming. Patients should take the drug only for as long as it is prescribed, in the amounts prescribed, and no more frequently than prescribed.

Butalbital M (OH) Organisms Affected

Humans and other mammals